2022
Conferences & Events
2022
7 - 8 December 2022, AI Enhanced Clinica Trials Summit - Boston, USA
Considering both #patientexperience and internal-process perspectives, the AI -Enhanced Clinical Trials Summit organized by Kisaco Research will take a closer look at how available and scalable AI technologies are accelerating and improving clinical trials.
7 December 2022, Simq Conference
Earlier today our CEO gave his contribution to the Simq Conference with a presentation entitled Hyper-accelerate drug and medical device development using AI & Modeling and Simulation following FDA and EMA's recommendations.
29 November 2022, Clinical Evidence - What is sufficient under MDR
Together with the AKRA TEAM we invite you to participate to a joint webinar on in silico evidence and discover how the use of In Silico Trials can make safer products, reduce development time, and innovate the R&D process.
17 - 20 November 2022, CNS Summit, Boca Raton, USA
We are thrilled to announce that our VP Sales&Marketing Mario Torchia will join the CNS Summit 2022, a community of #innovators and industry leaders who are not afraid to challenge the status quo.
15 - 16 November 2022, Redifining Early Stage Investments (RESI) San Francisco, USA
Our CEO Luca Emili joins the Digital Resi 2022 edition on November 15-16, with the aim of maximizing our efforts to find partners who are a fit for our technology and stage of development.
8 - 10 November 2022, BiotechX - Basel, Switzerland
We are among the most innovative startups selected to exhibit and be part of an ecosystem that allows pharma companies to scout the latest technologies and help benchmark and develop partnerships.
27 - 28 October 2022, Octane Medical Innovation Forum - California, USA
We are thrilled to announce that InSilicoTrials is one of the top medical innovation startup companies chosen by Octane OC to pitch in the Startup Showcase room.
26 - 28 October 2022, 38th Congress of the European Commitee for Treatment and Research of MS - Amsterdam, Netherlands
We are happy to announce we will be present at ECTRIMS 2022, eager to meet participants involved in Multiple Sclerosis (MS) research from all over the world and to share our newest insights, while strengthening our network.
24 - 26 October 2022, Bio Europe - Leipzig, Germany
For two days, InSilicoTrials' team was attending #bioeurope in Leipzig from October 24-26. We would love to introduce you to the suite of solutions we can offer to derisk your clinical trial and medicaldevices' development using in silico methods
20 - 21 October 2022, Frontiers Health 2022 - Milan, Italy
Frontiers Health is one of the premier global digitalhealth innovation events, with a strong focus on digitaltherapies, breakthrough #echnologies, healthcare transformation, investments, and ecosystem development. Our CEO, Luca Emili presented InSilicoTrials within the Discovery Session.
12 - 14 October 2022, BioJapan - Pacifico Yokohama
Featuring a twinned exhibition, seminars, and a large-scale partnering platform expected to bring together over 900 companies seeking to forge new partnerships, we have been part of BioJapan as part of the Italian Delegation of ITA - Italian Trade Agency from 12 to 14 October 2022 in Yokohama.
11 - 14 October 2022, World Vaccine Congress - Barcelona, Spain
For 3 days we were at the startups showcased as part of the Start-up Zone during the The World Vaccine Congress, the largest, most established meeting dedicated to #vaccines.
5 - 8 October 2022, 63rd National Congress of the Italian Society of Nephrology - Rimini, Italy
Our colleague Vincenzo Carbone, PhD presented the poster entitled ADPKD Segmentator - A prognostic tool for Autosomal Dominant Polycystic Kidney Disease.
29 September 2022, Technology Forum Life Science
Our CEO Luca Emili underlining how modeling and simulation can support pharma companies at the panel Technology Transfer in Life Sciences during the Technology Forum Life Sciences Week 2022.
18-22 September 2022, World Congress on Particle Technology - Madrid, Spain
XPS is a high-performance simulation environment for granular flows in industry relevant settings that enables the user to understand, control and predict pharmaceutical unit operations leading to enhanced efficiency and improved product quality.
11-14 September 2022, Safety Pharmacology Society - Montreal, Canada
Roberta Bursi, PhD, InSilicoTrials' Co-Founder and Executive Vice President Research & Development was an invited speaker in the session "Current Status and Future Perspectives in AI-Based Drug Assessment"
7-8 September 2022, Inteligent Health AI - Basel
Our CEO Luca Emili gave a talk about "Hyper-Acelerate drug and medical device development using AI and Modeling following FDA's and EMA's recommendations.
6-9 September 2022, VPH Conference - Porto, Portugal
Chiara Nicolò and Cristina Vaghi presenting two posters at the VPH Conference: Clinical Trial Simulations in Oncologic Patients using the InSilicoONCO Suite.
Early in silico assesment of the drug-induced proarrhytmic risk using the Drug Safety Suite
1-2 September 2022, Tech Tour - Braga, Portugal
InSilicoTrials was selected to pitch at Tech Tour Braga 2022 among the 33 most promising companies, selected from 100+ applications.
30 June 2022, Plug & Play Venture Day - Basel
Our Vice President Sales & Marketing Mario Torchia had the opportunity to pitch and talk about our vision and unique cloud platform during the Plug and Play Venture Day Basel.
29-30 June 2022, Bits and Pretzels HealthTech Conference
Next Generation Healthcare - Spotlight on Digital Twin: our CEO Luca Emili took part in this fireside chat session during the Bits & Pretzels HealthTech Conference on June 30th.
27-29 June 2022, 7th International Conference on Computational and Mathematical Biomedical Engineering
Our PM Alessia Baretta gave the talk Web Based Tool for Radial Force Test of Self-Expandable Transcatheter at CMBE 2022 hosted by Politecnico di Milano.
13 - 16 June 2022, Bio International Convention
Our CEO Luca Emili and VP Sales&Marketing Mario Torchia joined Bio International Convention and had fruitful conversations on the importance of digitaltwin and biosimulation in the digitalization of the R&D processes.
27th May 2022, VPH Summer School (6th Edition)
InSilicoTrials’ CEO Luca Emili among the panelists of the QUAES-UPF Roundtable “Good Practices and Ethics in in silico Medicine and e-Health” closing the 6th Edition of the VPH Summer School.